Shorena Janelidze
21 – 30 of 208
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Comparison of CSF biomarkers in multiple sclerosis patients treated with natalizumab and rituximab
- Contribution to journal › Article
-
Mark
Machine learning prediction of tau-PET in Alzheimer's disease using plasma, MRI, and clinical data
- Contribution to journal › Article
-
Mark
Plasma Glial Fibrillary Acidic Protein and Neurofilament Light Are Elevated in Bipolar Depression : Evidence for Neuroprogression and Astrogliosis
- Contribution to journal › Article
-
Mark
Plasma p-tau immunoassays in clinical research for Alzheimer's disease
- Contribution to journal › Scientific review
-
Mark
A comparison of p-tau assays for the specificity to detect tau changes in Alzheimer's disease
- Contribution to journal › Article
-
Mark
Prediction of amyloid and tau brain deposition and cognitive decline in people with Down syndrome using plasma biomarkers : a longitudinal cohort study
- Contribution to journal › Article
-
Mark
The impact of disease activity and interferon-α on the nervous system in systemic lupus erythematosus
- Contribution to journal › Article
-
Mark
Plasma MTBR-tau243 biomarker identifies tau tangle pathology in Alzheimer's disease
- Contribution to journal › Article
-
Mark
The Alzheimer's Association Global Biomarker Standardization Consortium (GBSC) plasma phospho-tau Round Robin study
- Contribution to journal › Article
-
Mark
Soluble cerebral Aβ protofibrils link Aβ plaque pathology to changes in CSF Aβ42/Aβ40 ratios, neurofilament light and tau in Alzheimer’s disease model mice
- Contribution to journal › Article
